​Venture Vitality Roundtable

​Theme: Clinical Trials

​Clinical trials are undergoing a massive transformation.

​Rising costs, slower recruitment, and increasing complexity have created opportunities for a new generation of companies to reshape how research gets done.

​The biggest opportunities in healthcare may not be the therapies themselves.

​They may be the companies building the infrastructure that makes clinical innovation faster, more efficient, and more inclusive.

​This month's discussion

​We're exploring four questions shaping the future of clinical trial innovation:

​💡 Can AI finally solve the patient recruitment problem?

​Finding the right patients remains one of the biggest bottlenecks in research. Investors are backing companies that use AI to identify eligible patients, predict enrollment success, and optimize trial protocols, helping sponsors reduce timelines and costs.

​💡 Will decentralized clinical trials become the new standard?

​Digital health platforms, wearable devices, and remote patient monitoring solutions are making trials more accessible, improving patient retention, and expanding participation beyond traditional research sites.

​💡 Can real-world data and synthetic control arms accelerate drug development?

​Clinical trials are increasingly using real-world evidence and advanced data models to support regulatory decisions and reduce the need for large control groups. Companies that can turn fragmented healthcare data into actionable insights are attracting significant investor attention.

​💡 How do we make clinical trials more inclusive and representative of the real world?

​For decades, many clinical trials have been heavily dependent on participants from a limited set of demographics, often underrepresenting Latino, African, Middle Eastern, Asian, and other communities.

​The next generation of clinical research is focused on increasing diversity, improving access, and generating evidence that better reflects the populations that therapies are designed to serve.

​Investors are watching companies that can improve participant diversity, reduce healthcare disparities, and build more inclusive research infrastructure.

​Who is this roundtable for?

​This private discussion is designed for:

​• Accredited Investors
• Limited Partners (LPs)
• General Partners (GPs)
• Venture Capital Firms
• Family Offices
• Fund Managers
• Venture Studios
• Startup Banking Leaders
• Pharmaceutical and Life Science Executives
• Clinical Research Organizations (CROs)
• Healthcare Executives and Strategic Partners seeking early insights into the future of clinical innovation.

​Why attend?

​This is more than a networking event.

​Participants gain:

​• Early visibility into emerging investment themes before they become mainstream.

​• Direct access to founders, operators, and experts building the future of clinical research.

​• Insights into where capital is flowing across AI, decentralized trials, patient recruitment, and real-world evidence.

​• High-quality relationships with aligned investors and strategic collaborators.

​• A better understanding of the technologies and infrastructure that could reduce trial costs, accelerate approvals, and improve patient access.

​• Opportunities to discover companies and partnerships that align with your investment thesis and portfolio strategy.

​Clinical trial innovation is becoming one of the most important infrastructure opportunities in healthcare.

​The companies that make research faster, smarter, and more inclusive may create enormous value over the next decade.

Upcoming Venture Vitality Themes

​September: Men's Health

​October: Mental Health

​November: Women's Health

​December: AgeTech and Senior Care

​Which clinical trial trend are you watching most closely?

​Seed to Scale | We Guide. Match. Build, Together.